6.47 USD
▲-0.10+2.37%
盘后 6.22 -1.61%
2026-08-03
市值
$664.20M
市盈率
—
EPS
-1.08
股息率
—
52 周区间
2.37 – 7.11
成交量
1.24M
Beta
2.22
目标价
13.80
52W 低 2.3752W 高 7.11
价格走势
公司简介
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.